Where Anti-neuronal antibodies (PTLDS) is reported
Also listed as: Autoimmune neurological
| Condition | Direction | Compared against | Associated symptoms | Source |
|---|---|---|---|---|
| Lyme Disease | ↕ inconsistent | healthy controls | Cognitive, neuropathic symptoms | Aucott et al. 2014 |
Frequently asked questions
In which conditions is Anti-neuronal antibodies (PTLDS) altered?
In the OSMF atlas Anti-neuronal antibodies (PTLDS) is reported in Lyme Disease. It is mixed in 1 across 1 entries.
Is there a standard clinical test for Anti-neuronal antibodies (PTLDS)?
The atlas entries for Anti-neuronal antibodies (PTLDS) do not carry a LOINC code, which usually means the marker was measured with research assays or study-specific methods rather than a routine clinical panel.
Is one abnormal Anti-neuronal antibodies (PTLDS) result diagnostic?
No single biomarker result is diagnostic of any of these conditions. Findings reflect group averages from published cohorts with substantial overlap between patients and controls.
Cite this page
Subscribe on Substack
Last reviewed: 2026-06-29 · Browse: Biomarker Index · All marker pages · Biomarker Atlas
Disclaimer: Educational synthesis of peer-reviewed research; not medical advice. Findings are group-level and vary with study design. Discuss any result with a qualified clinician.